Groowe Groowe / Newsroom / ELTX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ELTX News

Elicio Therapeutics, Inc. Common Stock

ELTX SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Elicio Therapeutics, Inc. for Possible Securities Law Violations

accessnewswire.com
ELTX

Elicio Therapeutics Investigation Initiated: SueWallSt Investigates the Officers and Directors of Elicio Therapeutics (ELTX)

prnewswire.com
ELTX

Levi & Korsinsky Announces Investigation of Securities Claims Against Elicio Therapeutics, Inc. (ELTX)

accessnewswire.com
ELTX

ELTX INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Elicio Therapeutics, Inc.

globenewswire.com
ELTX

Form 8-K

sec.gov
ELTX

Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer

globenewswire.com
ELTX

Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology

globenewswire.com
ELTX

Form 8-K

sec.gov
ELTX

Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates

globenewswire.com
ELTX

Electra Therapeutics Announces First Patient Dosed in Phase 1 Study of Ipsoprubart (ELA026) in T Cell Malignancies

globenewswire.com
ELTX